Welcome!

News Feed Item

Fc Protein and Glycoengineered Antibodies Market

DUBLIN, March 5, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and) has announced the addition of the "Fc Protein and Glycoengineered Antibodies Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies. Developed through introduction of modifications in monoclonal antibodies, the aim is to develop antibodies with improved efficacy.

Research done in the last decade to develop engineered antibodies has yielded a rich knowledge base on how to develop and market these next generation antibodies. These therapeutic antibodies seem to be more promising, with improved properties when compared to their ancestors. There are several molecules in phase II / III clinical trials and a few waiting for approvals. In addition, a large number of molecules are also in pre-clinical trials and are expected to progress through various stages of drug development over the next ten years.

The Fc Protein and Glycoengineered Antibody Market, 2013-2023 report was commissioned to examine the various aspects of engineering an antibody to develop novel drugs and address several oncology specific diseases. With the market being fairly new, the report examines several elements of developing these next generation antibodies including technologies used for their production, site of engineering in an antibody and molecules in pipeline.

For the purposes of this report, engineered antibodies are defined as antibodies which have been modified in their Fc region. The two types of modification considered are:

  • Fc Glycoengineering (referred to as Glycoengineering' in the report)
  • Fc Protein engineering

Key Topics Covered:

1. EXECUTIVE SUMMARY

2. INTRODUCTION

3. ENGINEERED ANTIBODIES: OVERVIEW AND BACKGROUND

4. GLYCOENGINEERED ANTIBODIES MARKET, 2012 - 2023

5. Fc PROTEIN ENGINEERED ANTIBODIES MARKET, 2013 - 2023

6. TECHNOLOGICAL PLATFORMS FOR ENGINEERED ANTIBODIES

7. PROFILES OF LEADING COMPANIES

8. SWOT ANALYSIS

9. CONCLUSIONS

10. APPENDIX 1: TABLES

11. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS


Companies Mentioned:

  • ABN AMRO Capital
  • AVID Bioservices
  • Absolute Antibody
  • Accurus Biosciences
  • Affitech A/S
  • Allos Therapeutics
  • Amgen
  • Andromeda Biotech
  • Applied Molecular Evolution (AME)
  • Astra Zeneca
  • BioMedinvest
  • BioWa
  • BioXcellence
  • BioXpress Therapeutics
  • Bioceros
  • Biocon
  • Biogen Idec
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • CSL
  • Celltrion
  • Centocor Ortho Biotech
  • Cephalon
  • ChemoCentryx
  • Chugai Pharmaceuticals
  • Deutsche Venture Capital
  • Diamyd Medical
  • Dong-A Pharmaceutical
  • Eli Lilly
  • Eureka Therapeutics
  • Five Prime Therapeutics
  • GSK
  • Genentech
  • Gilde Investment Management
  • Global Life Science Ventures
  • Glycart
  • Glycode
  • Glycotope
  • Green Cross Corporation
  • Greenovation
  • Halozyme Therapeutics
  • Hanwha Chemical
  • Human Genome Sciences
  • ISU Abxis
  • Ildong Pharmaceuticals
  • ImmunGene
  • Inhibrx
  • InvivoGen
  • KaloBios
  • Kyowa Hakko Kirin
  • Laboratoire français du Fractionnement et des Biotechnologies (LFB)
  • Life Science Pharmaceuticals
  • Lonza
  • MacroGenics
  • MedImmune
  • Meiji Seika Pharma
  • Mentrik Biotech
  • Merck-GlycoFi
  • Micromet
  • MilleGen
  • Minapharm Pharmaceuticals
  • Morphosys
  • Mylan
  • NKT Therapeutics
  • Nippon Kayaku
  • Nippon Shinyaku
  • Novartis
  • Novartis Venture Fund
  • Ortho-McNeil Janssen Pharmaceutical
  • PDL Biopharma
  • Pfizer
  • Pikamab
  • Pinnacle Oncology Hematology
  • PlantForm Corporation
  • ProStrakan
  • Quester Capital Management
  • Regeneron Pharmaceuticals
  • Roche
  • Sandoz
  • Sanofi
  • Schnell Biopharma
  • Seattle Genetics
  • Servier
  • Shanghai CP Guojian
  • SiaMedExpress
  • Sorrento Therapeutics
  • Synthon-Biolex
  • TG Therapeutics
  • Taiho Pharmaceutical
  • Teva Pharmaceuticals
  • Trubion
  • Vivalis
  • Watson Pharmaceuticals
  • WuXi AppTec
  • Xencor
  • Zymeworks
  • arGEN-X
  • biOasis Technologies
  • rEVO Biologic

For more information visit http://www.researchandmarkets.com/research/r8hfhg/fc_protein_and


Media Contact: Laura Wood , +353-1-481-1716, [email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
While some vendors scramble to create and sell you a fancy solution for monitoring your spanking new Amazon Lambdas, hear how you can do it on the cheap using just built-in Java APIs yourself. By exploiting a little-known fact that Lambdas aren’t exactly single threaded, you can effectively identify hot spots in your serverless code. In his session at 20th Cloud Expo, David Martin, Principal Product Owner at CA Technologies, will give a live demonstration and code walkthrough, showing how to o...
In his keynote at 19th Cloud Expo, Sheng Liang, co-founder and CEO of Rancher Labs, discussed the technological advances and new business opportunities created by the rapid adoption of containers. With the success of Amazon Web Services (AWS) and various open source technologies used to build private clouds, cloud computing has become an essential component of IT strategy. However, users continue to face challenges in implementing clouds, as older technologies evolve and newer ones like Docker c...
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
Developers want to create better apps faster. Static clouds are giving way to scalable systems, with dynamic resource allocation and application monitoring. You won't hear that chant from users on any picket line, but helping developers to create better apps faster is the mission of Lee Atchison, principal cloud architect and advocate at New Relic Inc., based in San Francisco. His singular job is to understand and drive the industry in the areas of cloud architecture, microservices, scalability ...
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
@DevOpsSummit has been named the ‘Top DevOps Influencer' by iTrend. iTred processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @DevOpsSummit ranked as the number one ‘DevOps Influencer' followed by @CloudExpo at third, and @MicroservicesE at 24th.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
NHK, Japan Broadcasting, will feature the upcoming @ThingsExpo Silicon Valley in a special 'Internet of Things' and smart technology documentary that will be filmed on the expo floor between November 3 to 5, 2015, in Santa Clara. NHK is the sole public TV network in Japan equivalent to the BBC in the UK and the largest in Asia with many award-winning science and technology programs. Japanese TV is producing a documentary about IoT and Smart technology and will be covering @ThingsExpo Silicon Val...
NHK, Japan Broadcasting, will feature the upcoming @ThingsExpo Silicon Valley in a special 'Internet of Things' and smart technology documentary that will be filmed on the expo floor between November 3 to 5, 2015, in Santa Clara. NHK is the sole public TV network in Japan equivalent to the BBC in the UK and the largest in Asia with many award-winning science and technology programs. Japanese TV is producing a documentary about IoT and Smart technology and will be covering @ThingsExpo Silicon Val...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.